======= ZMYND11 ======= == Gene Information == * **Official Symbol**: ZMYND11 * **Official Name**: zinc finger MYND-type containing 11 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10771|10771]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15326|Q15326]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZMYND11&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZMYND11|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608668|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene was first identified by its ability to bind the adenovirus E1A protein. The protein localizes to the nucleus. It functions as a transcriptional repressor, and expression of E1A inhibits this repression. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Chromatin reader that specifically recognizes and binds histone H3.3 trimethylated at 'Lys-36' (H3.3K36me3) and regulates RNA polymerase II elongation. Does not bind other histone H3 subtypes (H3.1 or H3.2) (By similarity). Colocalizes with highly expressed genes and functions as a transcription corepressor by modulating RNA polymerase II at the elongation stage. Binds non- specifically to dsDNA (PubMed:24675531). Acts as a tumor- suppressor by repressing a transcriptional program essential for tumor cell growth. {ECO:0000250|UniProtKB:Q8R5C8, ECO:0000269|PubMed:10734313, ECO:0000269|PubMed:16565076, ECO:0000269|PubMed:24675531}. |PWWP| |Bromodomain| |regulation of transcription elongation from RNA polymerase II promoter| |negative regulation of JNK cascade| |negative regulation of I-kappaB kinase/NF-kappaB signaling| |negative regulation of stress-activated protein kinase signaling cascade| |negative regulation of stress-activated MAPK cascade| |regulation of DNA-templated transcription, elongation| |methylated histone binding| |negative regulation of extrinsic apoptotic signaling pathway| |double-stranded DNA binding| |chromosome| |regulation of extrinsic apoptotic signaling pathway| |negative regulation of MAPK cascade| |regulation of JNK cascade| |defense response to virus| |negative regulation of apoptotic signaling pathway| |regulation of stress-activated MAPK cascade| |regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of stress-activated protein kinase signaling cascade| |transcription corepressor activity| |response to virus| |regulation of apoptotic signaling pathway| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |negative regulation of intracellular signal transduction| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |chromatin organization| |viral process| |regulation of cellular response to stress| |regulation of MAPK cascade| |symbiotic process| |interspecies interaction between organisms| |zinc ion binding| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |defense response to other organism| |negative regulation of cell death| |negative regulation of cellular protein metabolic process| |chromosome organization| |immune effector process| |negative regulation of protein metabolic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |defense response| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |regulation of phosphorylation| |negative regulation of response to stimulus| |regulation of cell death| |negative regulation of gene expression| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.73| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.75| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.77| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.78| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11160 * **Expression level (log2 read counts)**: 6.15 {{:chemogenomics:nalm6 dist.png?nolink |}}